TaiDoc Technology | Evaluate

Despair engulfs smaller device companies

The nightmare on the public markets is not confined to the bigger groups.

Smaller device makers put in a muted performance

Mid- and small-cap medtechs find themselves at the mercy of government responses to the Covid-19 pandemic.

January 08, 2020

2019 was all about execution for smaller device makers

New products and strategic execution buoyed mid and small-cap medtechs, while safety worries took down one former high-flier.

November 26, 2014

Bayer’s diabetes devices could work for an insulin company